Toggle Main Menu Toggle Search

Open Access padlockePrints

Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD

Lookup NU author(s): Dr Charlie Tomson


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.Purpose of Review: To summarize and explain the new guideline on blood pressure (BP) management in chronic kidney disease (CKD) published by Kidney Disease: Improving Global Outcomes (KDIGO), an independent global nonprofit organization which develops and implements evidence-based clinical practice guidelines in kidney disease. KDIGO issued its first clinical practice guideline for the Management of Blood Pressure (BP) in Chronic Kidney Disease (CKD) for patients not receiving dialysis in 2012 and now updated the guideline in 2021. Recent Findings: Recommendations in this update were developed based on systematic literature reviews and appraisal of the quality of the evidence and strength of recommendation following the “Grading of Recommendations Assessment, Development and Evaluation” (GRADE) approach. The updated guideline includes five chapters covering BP measurement techniques, lifestyle interventions for lowering BP, and management of BP in three target populations, namely adults (with and without diabetes), kidney transplant recipients, and children. A dedicated chapter on BP measurement emphasizing standardized preparation and measurement protocols for office BP measurement is a new addition, following protocols used in large randomized trials of BP targets with pivotal clinical outcomes. Summary: Based on the available evidence, and in particular in the CKD subgroup of the SPRINT trial, the 2021 guideline suggests a systolic BP target of <120 mm Hg, based on standardized measurements, for most individuals with CKD not receiving dialysis, with the exception of kidney transplant recipients and children. This recommendation is strictly contingent on the measurement of BP using standardized office readings and not routine office readings.

Publication metadata

Author(s): Mann JFE, Chang TI, Cushman WC, Furth SL, Ix JH, Hou FF, Knoll GA, Muntner P, Pecoits-Filho R, Sarnak MJ, Tomson CRV, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Cheung AK

Publication type: Review

Publication status: Published

Journal: Current Cardiology Reports

Year: 2021

Volume: 23

Issue: 9

Print publication date: 01/09/2021

Online publication date: 16/08/2021

Acceptance date: 30/04/2021

ISSN (print): 1523-3782

ISSN (electronic): 1534-3170

Publisher: Springer


DOI: 10.1007/s11886-021-01559-3